Company profile

Eko Health

Cardiology & Cardiovascular HealthGrowth stage

Company profile

About Eko Health

Eko brings together stethoscopes, powerful software, and AI-supported analysis to elevate the way we detect cardiovascular disease.

Company description Eko Health official website

Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Eko Health?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • atrial fibrillation
  • heart disease
  • heart failure with reduced ejection fraction
  • heart murmurs
  • low ejection fraction
  • lung disease
  • structural heart disease

Who it serves

  • Clinics
  • Health Systems
  • Life Science/Clinical Trials
  • Providers
  • Veterinary

Deployment & integration

Cloud Saas · Embedded · Hybrid deployment with recorded integration context.

Geographic context

MarketsSub-Saharan Africa · United States
Company sourceOfficial website

Company milestones

Platform expansion

CMS finalized OPPS payment for SENSORA Platform expanding reimbursement in hospital-associated outpatient care; launched AI solution for veterinary care with Boehringer Ingelheim; published TRICORDER Study in The Lancet; DAMSUN-HF Study in Sub-Saharan Africa

Partnerships

Recorded partners

  • 3M Littmann
  • Boehringer Ingelheim
  • FIGS
  • Guthrie
  • Origin Healthcare
  • Sutter Health
  • Wayne General Hospital

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

3M™ Littmann® CORE Digital Stethoscope

Trusted Littmann performance combined with Eko's digital innovation and AI

Device · EmbeddedCompany source

CORE 500™ Digital Stethoscope

Modern stethoscope replacement with 3-lead ECG, AI insights, and 8x sound improvement

Device · EmbeddedCompany source

CORE™ Digital Attachment

Digital attachment to upgrade existing stethoscopes with Eko technology

Device · EmbeddedCompany source

Eko AI

FDA-cleared AI for detecting murmurs, AFib, and low ejection fraction

Software · Cloud SaaSCompany source

Eko AI (Murmur, AFib, Low Ejection Fraction Detection)

FDA-cleared AI algorithms for detecting murmurs, AFib, and low ejection fraction

Software · Cloud SaaSCompany source

Eko Telehealth Platform

Telehealth-compatible platform for remote cardiac and pulmonary auscultation

Platform · Cloud SaaSCompany source

Eko Veterinary AI Solution

Purpose-built AI solution for detecting heart murmurs in veterinary care

Software · EmbeddedCompany source

SENSORA® Platform

Enterprise AI platform for cardiac disease detection across health systems

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

2x more likely to detect heart disease

Providers using Eko vs traditional stethoscope

8x sound improvement

CORE 500 compared to traditional stethoscope

Over 60% of heart diseases go undiagnosed

Problem statement addressed by Eko

DAMSUN-HF Study (Sub-Saharan Africa)

Detecting heart failure with reduced ejection fraction in Sub-Saharan Africa

Specialist-level heart failure detection using Eko's AI-enabled stethoscope

Guthrie

Improving efficiency in virtual exams with high-quality auscultation

Efficiency in virtual exams is as good as in-person visits

Origin Healthcare

Delivering high-acuity care at home using Eko's telehealth platform

Successfully delivers high-acuity care at home

Primary Care Settings (TRICORDER Study)

Real-world evaluation of AI-enabled stethoscopes in primary care

Increased detection when Eko AI-enabled stethoscopes are used in primary care

Sub-Saharan Africa Healthcare Facilities

Detecting heart failure with reduced ejection fraction in resource-limited settings

Specialist-level heart failure detection using Eko's AI-enabled stethoscope

Sutter Health

Catalyzing the evolution of patient experience through digital patient care technologies

Bringing care to the patient through technologies like Eko

TRICORDER Study (Primary Care)

Real-world evaluation of AI-enabled stethoscopes in primary care settings

Increased detection when Eko AI-enabled stethoscopes are used in primary care

Wayne General Hospital

Deploying AI-assisted cardiac detection in rural Mississippi

Partnership to deploy AI-assisted cardiac detection in rural setting

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Ann Lee-Karlon

Ann Lee-Karlon

Board Member/Advisor

LinkedIn

Dr. Steven Steinhubl

Chief Medical Officer

LinkedIn
Jason Bellet

Jason Bellet

Co-Founder, Chief Business Officer, Board Director

LinkedIn

Tyler Crouch

Co-Founder & Lead Product Architect

LinkedIn

Karl Larson

Vice President of Global Supply Chain

LinkedIn

06 · Company updates

Updates from Eko Health

Recent articles published on Eko Health's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Cardiology & Cardiovascular Health

Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon